<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39375336</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Strengthening and expanding capacities in clinical trials: advancing pandemic prevention, preparedness and response in Africa.</ArticleTitle><Pagination><StartPage>8662</StartPage><MedlinePgn>8662</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8662</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-53126-3</ELocationID><Abstract><AbstractText>Enhancing the clinical trial capabilities within Africa is essential to augment the continent’s pandemic prevention, preparedness and response efforts. Here, we describe the critical challenges of clinical trials in Africa and draw upon the lessons learnt from the <u>Con</u>sortium for <u>C</u>OVID-19 <u>Va</u>ccine <u>C</u>linical <u>T</u>rials (CONCVACT) experience, such as the importance of regional collaboration, capacity building and establishing standardized protocols.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ndembi</LastName><ForeName>Nicaise</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5131-3136</Identifier><AffiliationInfo><Affiliation>Africa Centres for Disease Control and Prevention (Africa CDC), Haile Garment Square, Addis Ababa, Ethiopia. Nicaisen@africacdc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mekonen</LastName><ForeName>Tadesse T</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Avacare Health, Grand bay, Mauritius, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Folayan</LastName><ForeName>Morenike Oluwatoyin</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Department of Child Dental Health, Obafemi Awolowo University, Ile-Ife, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dereje</LastName><ForeName>Nebiyu</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Africa Centres for Disease Control and Prevention (Africa CDC), Haile Garment Square, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruger</LastName><ForeName>Adriaan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nuvoteq, Hazelwood Incubator, 47 Hazelwood Rd, Hazelwood, Pretoria, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fokam</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1501-2763</Identifier><AffiliationInfo><Affiliation>Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Temfack</LastName><ForeName>Elvis</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Africa Centres for Disease Control and Prevention (Africa CDC), Haile Garment Square, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raji</LastName><ForeName>Tajudeen</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Africa Centres for Disease Control and Prevention (Africa CDC), Haile Garment Square, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nachega</LastName><ForeName>Jean</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2862-4443</Identifier><AffiliationInfo><Affiliation>Stellenbosch University, Faculty of Medicine and Health Sciences, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boum</LastName><ForeName>Yap</ForeName><Initials>Y</Initials><Suffix>2nd</Suffix><AffiliationInfo><Affiliation>Institut Pasteur de, Bangui, Central African Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crowell</LastName><ForeName>Trevor A</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0001-5947-265X</Identifier><AffiliationInfo><Affiliation>Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngongo</LastName><ForeName>Alain Ngashi</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Africa Centres for Disease Control and Prevention (Africa CDC), Haile Garment Square, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mboup</LastName><ForeName>Souleymane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formations (IRESSEF), Diamniadio, Senegal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ntoumi</LastName><ForeName>Francine</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Fondation Congolaise pour la Recherche Médicale, Republic of Congo and Institute of Tropical Medicine, University of Tübingen, Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loots</LastName><ForeName>Glaudina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Science and Technology, Pretoria, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makanga</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Global Health EDCTP3 Joint Undertaking, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sow</LastName><ForeName>Samba</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Vaccine Development (CVD) at the Mali Ministry of Health and Social Development, Bamako, MD, Mali.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Salim Abdool</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-4986-2133</Identifier><AffiliationInfo><Affiliation>Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban and Mailman School of Public Health, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nkengasong</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Bureau of Global Health Security and Diplomacy, President's Emergency Plan for AIDS Relief, Washington, DC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI147331</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>US NIH R01 AI147331-04</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000349" MajorTopicYN="N" Type="Geographic">Africa</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057191" MajorTopicYN="N">Capacity Building</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39375336</ArticleId><ArticleId IdType="pmc">PMC11458601</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-53126-3</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-53126-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adebamowo, C. et al. Randomised controlled trials for Ebola: practical and ethical issues. Lancet384, 1423–1424 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4392883</ArticleId><ArticleId IdType="pubmed">25390318</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim, S. S. A. &amp; Sikazwe, I. Building on Pasteur’s legacy: producing vaccines in Africa. Lancet400, 2164–2166 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36528368</ArticleId></ArticleIdList></Reference><Reference><Citation>Africa CDC. African Union Commission launches consortium for COVID-19 vaccine clinical trial. Published 2020. The details can be found at https://africacdc.org/news-item/african-union-commission-launches-consortium-for-covid-19-vaccine-clinical-trial/ (2020).</Citation></Reference><Reference><Citation>World Health Organization. Pan African Clinical Trials Registry (PACTR). The details can be found at https://www.who.int/clinical-trials-registry-platform/network/primary-registries/pan-african-clinical-trials-registry-pactr.</Citation></Reference><Reference><Citation>Ndwandwe, D. E. et al. Practices and trends in clinical trial registration in the Pan African Clinical Trials Registry (PACTR): a descriptive analysis of registration data. BMJ Open12, e057474 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8796231</ArticleId><ArticleId IdType="pubmed">35078852</ArticleId></ArticleIdList></Reference><Reference><Citation>EU Commission. Clinical Trials Community Africa Network. Published 2023. The details can be found at https://cordis.europa.eu/project/id/101103299 (2023).</Citation></Reference><Reference><Citation>CEPI. The 100 Days Mission to Respond to Future Pandemic Threats. The details can be found at https://cepi.net/cepi-20-and-100-days-mission (2022).</Citation></Reference><Reference><Citation>Hwenda, L., Sidibe, M. &amp; Makanga, M. The African Medicines Agency: the key to unlocking clinical research in Africa. Lancet Glob. Health10, e1088–e1089 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35716676</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyirenda, T. et al. Strengthening capacity for clinical research in sub-Saharan Africa: partnerships and networks. Int. J. Infect. Dis.110, 54–61 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34216733</ArticleId></ArticleIdList></Reference><Reference><Citation>Africa CDC. Meeting Report: Optimizing Efficiency and Impact in the African Clinical Trials Ecosystem. Published 2023. The details can be found at https://africacdc.org/download/meeting-report-optimizing-efficiency-and-impact-in-the-african-clinical-trials-ecosystem/ (2023).</Citation></Reference><Reference><Citation>Africa CDC. Partnerships for African Vaccine Manufacturing (PAVM) Framework for Action. Published 2023. The details can be found at https://africacdc.org/download/partnerships-for-african-vaccine-manufacturing-pavm-framework-for-action/ (2023).</Citation></Reference><Reference><Citation>Nkengasong, J. N. &amp; Mankoula, W. Looming threat of COVID-19 infection in Africa: act collectively, and fast. Lancet395, 841–842 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7124371</ArticleId><ArticleId IdType="pubmed">32113508</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>